Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.06B |
| 2 |
Apple
AAPL
|
$625M |
| 3 |
UnitedHealth
UNH
|
$201M |
| 4 |
Cisco
CSCO
|
$192M |
| 5 |
Johnson & Johnson
JNJ
|
$182M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$608M |
| 2 |
Broadcom
AVGO
|
$240M |
| 3 |
United Rentals
URI
|
$212M |
| 4 |
CRH
CRH
|
$200M |
| 5 |
Pfizer
PFE
|
$174M |
Sector Composition
| 1 | Technology | 18.69% |
| 2 | Financials | 17.09% |
| 3 | Industrials | 13.06% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Healthcare | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Envela
ELA
$194M
| $364K | ﹤0.01% |
78,711
-8,684
| -10% | -$40.1K |
|
|
RDIB
3102
Reading International Class B
RDIB
$294M
| $362K | ﹤0.01% |
24,836
-591
| -2% | -$8.62K |
|
3103
Apyx Medical
APYX
$74.1M
| $362K | ﹤0.01% |
265,857
-83,336
| -24% | -$113K |
|
3104
Telus
TU
$25.3B
| $361K | ﹤0.01% |
22,579
-514
| -2% | -$8.23K |
|
3105
CKX Lands
CKX
$24.2M
| $360K | ﹤0.01% |
27,298
-2,578
| -9% | -$34K |
|
3106
Lazydays
GORV
$10.6M
| $356K | ﹤0.01% |
2,943
| – | – |
|
|
AZUL
3107
DELISTED
Azul
AZUL
| $351K | ﹤0.01% |
45,169
-2,459
| -5% | -$19.1K |
|
|
ELEV
3108
DELISTED
Elevation Oncology
ELEV
| $351K | ﹤0.01% |
+68,348
| New | +$351K |
|
3109
ReposiTrak
TRAK
$314M
| $350K | ﹤0.01% |
22,104
-4,581
| -17% | -$72.6K |
|
3110
Koss Corp
KOSS
$58.2M
| $350K | ﹤0.01% |
136,145
-360
| -0.3% | -$925 |
|
|
WMPN
3111
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $348K | ﹤0.01% |
28,185
| – | – |
|
3112
Relmada Therapeutics
RLMD
$54.8M
| $343K | ﹤0.01% |
73,820
| – | – |
|
3113
Biote Corp
BTMD
$110M
| $343K | ﹤0.01% |
59,113
-17,479
| -23% | -$101K |
|
3114
Lake Shore Bancorp
LSBK
$103M
| $343K | ﹤0.01% |
29,076
+2,138
| +8% | +$25.2K |
|
3115
Purple Innovation
PRPL
$122M
| $338K | ﹤0.01% |
194,128
-152,766
| -44% | -$266K |
|
3116
Kentucky First Federal Bancorp
KFFB
$25.3M
| $338K | ﹤0.01% |
88,420
-484
| -0.5% | -$1.85K |
|
3117
ImmuCell
ICCC
$57.3M
| $336K | ﹤0.01% |
63,401
+5,950
| +10% | +$31.5K |
|
3118
Cosan
CSAN
$2.47B
| $336K | ﹤0.01% |
25,938
+9,112
| +54% | +$118K |
|
|
GTHX
3119
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $335K | ﹤0.01% |
77,531
+865
| +1% | +$3.74K |
|
3120
Inotiv
NOTV
$56.3M
| $332K | ﹤0.01% |
30,329
| – | – |
|
3121
Traeger
COOK
$200M
| $326K | ﹤0.01% |
128,925
+17,664
| +16% | +$44.7K |
|
3122
CPI Aerostructures
CVU
$31.5M
| $326K | ﹤0.01% |
139,338
| – | – |
|
3123
CPI Card Group
PMTS
$162M
| $325K | ﹤0.01% |
18,196
-504
| -3% | -$9K |
|
3124
Flotek Industries
FTK
$336M
| $325K | ﹤0.01% |
86,814
| – | – |
|
3125
LINKBANCORP
LNKB
$270M
| $323K | ﹤0.01% |
46,544
+27,913
| +150% | +$194K |
|